0551 GMT October 05, 2022
In an interview with , Mehdi Safarinia noted that more than 26 companies of Pardis Technology Park were producing anti-coronavirus products, five of which were active in drug production.
Safarinia referred to Meem Medicine Producer Company as the first company obtained a license from the Food and Drug Administration today for its 'Saliravira' which reduced the symptoms of COVID-19 and also promisingly passed its trial phase successfully.
"Two companies of Pardis Technology Park were able to gain technical knowledge to produce vaccines, of which one is equipping its production lines to enter the market," he added.
Safarinia further said that eight more companies entered their products into the market by providing the hospitals with anti-coronavirus equipment.
"Three companies also worked in the field of diagnostic kits and other devices to enter the market and reduce some of the country's problems," the official stated.
He pointed out that some of the park's companies were active to produce disinfectants and masks, so, in the last two years, four companies have dedicated their production lines to the production of materials for eradicating the virus.
According to Safarnia 440 billion rials ($1.8 million) have been allocated to financing these companies.
The homemade coronavirus medicine 'Saliravira' was unveiled at the Science and Technology Office in Tehran in the presence of the president of Pardis Technology Park and the Saliravira producer Reza Ramezani, on June 7, 2021.